Medical News

RSS

New York's Medicaid advisory panel approves plan to cut health spending

The panel's compromise includes an annual spending cap and across-the-board Medicaid provider cuts. Meanwhile, other states also struggle with the rising cost of Medicaid and its impact on the budget.

25 Feb 2011

U.S.-Chile collaborate to study new long-acting local anesthetic derived from algae

A U.S.-Chile collaboration is bringing surgical patients closer to having a long-acting local anesthetic. In a randomized, double-blind trial, patients given neosaxitoxin, a new local anesthetic derived from algae, had significantly less postoperative pain and recovered about two days sooner than those given the commonly used local anesthetic bupivacaine.

25 Feb 2011

Poll finds 1 in 5 Americans think health law was repealed

Coverage continues regarding a Kaiser Family Foundation poll released Thursday that found a surprising degree of confusion about the status of the federal health overhaul.

25 Feb 2011

IPG Photonics fourth quarter revenues increase 86% year-over-year to $101 million

IPG Photonics Corporation today reported financial results for the fourth quarter of fiscal 2010 ended December 31, 2010.

25 Feb 2011

Romney responds: He's proud of Mass. health care overhaul

Some suggest the exchange between former Arkansas Governor Mike Huckabee, in which he criticized "RomneyCare," and former Massachusetts Governor Mitt Romney is a preview of the 2012 Republican presidential primary.

25 Feb 2011

General Nutrition Centers fourth quarter net income increases 56.3% to $19.8 million

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the year and quarter ended December 31, 2010.

25 Feb 2011

New policy research brief examines patients at risk of losing care under health center spending cuts

A new policy research brief released today by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at The George Washington University School of Public Health and Health Services examines the characteristics of patients whose access to health center services is at risk because of a potential $1.3 billion in direct spending cuts for community health centers.

25 Feb 2011

Stink bugs may worsen asthma, cause allergy

How rude! They sneak into your home uninvited and when you scare or smush them, they release a foul-smelling substance. "When stink bugs pop up in homes, do they cause allergy? There's not a lot of public information about it," says Nancy Sander, founder and president of Allergy & Asthma Network Mothers of Asthmatics (AANMA), the leading national family-founded nonprofit organization for people with asthma, allergies and related conditions. "So AANMA asked an allergist who knows."

25 Feb 2011

Redesign of donor-liver distribution network could increase transplants by 14%

A redesign of the nation's donor-liver distribution network developed by University of Pittsburgh researchers could result in several hundred more people each year receiving the transplants they need.

25 Feb 2011

NASA certifies Superfocus glasses for astronauts with presbyopia

Superfocus LLC, creators of Superfocus glasses (formerly known as TruFocals) the first adjustable-focus eyeglasses to treat presbyopia, announced today the flight certification of Superfocus by the National Aeronautics and Space Administration (NASA) for use by astronauts on Discovery's final spaceflight (STS-133) and aboard the International Space Station.

25 Feb 2011

First Super Glue, then dentist

In preparation for the Chicago Dental Society's 146th annual Midwinter Meeting, which will draw more than 30,000 dental professionals to Chicago this February, society members were asked about current trends, dental care tips and more. More than 300 of the society's member dentists responded to the fall 2010 survey.

25 Feb 2011

Enrollment commences in NORDIC implantable cardioverter defibrillator clinical trial

BIOTRONIK SE & Co. KG announced today the start of the NORDIC ICD clinical trial. The first implantable cardioverter defibrillator (ICD) patients were enrolled by its coordinating clinical investigator, Prof. Dr. Dietmar Bänsch at the University Hospital of Rostock and the investigator Dr. Stefan Kuster at the DRK Hospital of Mölln/Ratzeburg.

25 Feb 2011

New study discloses mechanism controlling Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

25 Feb 2011

Warner Chilcott fourth quarter revenue increases 1% to $694.4 million

Warner Chilcott plc today announced its results for the quarter and year ended December 31, 2010. As discussed more fully below, our financial position and results of operations in the quarter ended December 31, 2010 as compared to the prior year quarter were significantly impacted by several important transactions in 2009 and 2010.

25 Feb 2011

First Edition: February 25, 2011

Today's headlines include reports about developments in New York's Medicaid program and other state-level news.

25 Feb 2011

Discovery highlights unexpected role for killer protein in 'autophagy'

Scientists at Trinity College Dublin have made an important discovery concerning how fledgling cancer cells self-destruct, which has the potential of impacting on future cancer therapies. The Trinity research group, led by Smurfit Professor of Medical Genetics, Professor Seamus Martin and funded by Science Foundation Ireland, has just published their findings in the internationally renowned journal, Molecular Cell.

25 Feb 2011

AMAG fourth quarter total revenues increase to $17.2 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2010.

25 Feb 2011

Savient launches KRYSTEXXA in the U.S.

Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXA™ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.

25 Feb 2011

Tenet fourth quarter adjusted EBITDA increases 28.9% to $281 million

Tenet Healthcare Corporation today reported adjusted EBITDA of $281 million for the fourth quarter ended December 31, 2010, an increase of $63 million, or 28.9 percent, compared to $218 million for the fourth quarter of 2009. Net income attributable to common shareholders for the fourth quarter of 2010 was $74 million, or $0.14 per diluted share, compared to $21 million, or $0.04 per diluted share, for the fourth quarter of 2009.

25 Feb 2011

Stallergenes inaugurates new pollen-production factory

On 20 January, Stallergenes, the leading company worldwide in sublingual immunotherapy treatments for respiratory allergies, inaugurated its new pollen-production site in Amilly (Loiret department).

25 Feb 2011